Archive
FTSE 100 closes firmly higher; Ashtead Group top dog
Britain's blue-chip benchmark closed up nearly 86 points at 7,443, while the FTSE 250 added over 154 points at 19,311
Company
LON:RENE
ReNeuron Group PLC has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customisable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several unique and scalable exosome producer cell lines, its CustomEX ™ platform can be optimised for specific tissues targets and payloads leading to improvements in therapeutic outcome and a reduction in off-target effects. ReNeuron offers a delivery mechanism for a variety of payloads such as siRNA, mRNA, proteins, small molecules and genes.
298 stories · page 5 of 15
Archive
Britain's blue-chip benchmark closed up nearly 86 points at 7,443, while the FTSE 250 added over 154 points at 19,311
ReNeuron said it looks forward to "continuing to advance our clinical and business development activities in the months ahead".
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Karelian, UniVision, Cambria Africa, Bagir, Nautilus Marine, Stride Gaming and Patagonia Gold
Investments and investor services
The Dow Jones suffered a 300 point fall in the first half hour of trading
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The cell therapy specialist has two clinical trials underway and is looking at partnerships or licensing deals for its three major programmes
Investments and investor services
A look at the day's major movers, including Bidstack, EU Supply, ReNeuron, Inspirit Energy, Prospex, Ferrexpo and Hastings Group
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The company has released the latest data from a Phase IIa study of people with a blindness-causing condition called retinitis pigmentosa
ReNeuron Group PLC is at the forefront of stem cell science
Fosun Pharma is licensing the rights to the company’s CTX and hRPC cell therapy programmes
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at the day's major movers, including Photonstar, Starcom, Ncondezi, K3 Capital Group, Matomy Media, Tricorn Group and Prairie Mining
Investments and investor services
"Small gains are the order of the day aside from in the UK, where again sterling weakness has allowed the FTSE 100 to register some reasonable gains," says Christ Beauchamp from IG
Investments and investor services
A look at the day's major movers, including Gordon Dadds, Motif Bio, Proton Power, Regal Petroleum, Saga and Xeros Technology